Dhingra Kapil — SEC insider filings

SEC reporting owner CIK 1456849. 23 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-12-09 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Replimune Group, Inc. (REPL)Director9—5 legs · 64,669 sh · $2,263,85212
Black Diamond Therapeutics, Inc. (BDTX)Director7——7
FIVE PRIME THERAPEUTICS, INC. (FPRX)Director1——5
CARGO Therapeutics, Inc. (CRGX)Director4——4
LAVA Therapeutics NV (LVTX)Director2——3

Insider filings — Dhingra Kapil

FiledFormIssuerReported transactionsSource
2026-11-034Replimune Group, Inc. (REPL)Option exercise (M): 43,169 @ $1.75 · Sale (S): 21,500 @ $19 · Option exercise (M): 43,169 (derivative) @ $0EDGAR
2026-06-294Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-04-074Replimune Group, Inc. (REPL)Grant/award (A): 44,500 (derivative) @ $0EDGAR
2025-12-114Replimune Group, Inc. (REPL)Option exercise (M): 3,169 @ $1.75 · Sale (S): 3,169 @ $10.40 · Option exercise (M): 3,169 (derivative) @ $0EDGAR
2025-11-174LAVA Therapeutics NV (LVTX)Disposition to issuer (D): 30,000 · Disposition to issuer (D): 33,390 (derivative) @ $0EDGAR
2025-08-194CARGO Therapeutics, Inc. (CRGX)Disposition to issuer (D): 25,000 (derivative)EDGAR
2025-06-204CARGO Therapeutics, Inc. (CRGX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-06-124Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR
2025-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2025-02-184LAVA Therapeutics NV (LVTX)Grant/award (A): 33,390 (derivative) @ $0EDGAR
2024-06-064Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR
2024-06-064CARGO Therapeutics, Inc. (CRGX)Grant/award (A): 11,871 (derivative) @ $0EDGAR
2024-04-174CARGO Therapeutics, Inc. (CRGX)Grant/award (A): 49,265 (derivative) @ $0EDGAR
2024-04-034Replimune Group, Inc. (REPL)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2023-05-174Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2023-04-044Replimune Group, Inc. (REPL)Grant/award (A): 25,200 (derivative) @ $0EDGAR
2022-06-134Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-04-054Replimune Group, Inc. (REPL)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2021-06-224Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-04-194FIVE PRIME THERAPEUTICS, INC. (FPRX)Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2021-04-054Replimune Group, Inc. (REPL)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2021-01-224Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 29,842 (derivative) @ $0EDGAR
2020-12-094Replimune Group, Inc. (REPL)Option exercise (M): 40,000 @ $1.75 · Sale (S): 24,675 @ $45.09 · Sale (S): 13,523 @ $46.22 · Sale (S): 1,802 @ $47.04 · Option exercise (M): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1456849 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs